Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651359 · ClinicalTrials.gov registry record · NA
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
A NA study of Prostate Cancer, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 3
- Study locations
NCT06651359: Recruiting NA study of Prostate Cancer, sponsored by University of Oklahoma.
NCT06651359 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 248 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06651359, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their quality of life.
Primary Outcome
The proportion of patients in the intervention arm reporting increased QoL using the Functional Assessment of Cancer Therapy - Prostate (FACT-P) survey. FACT-P has five subscales: 1. Physical Well-Being- Evaluate symptoms like pain and energy. 2. Social/Family Well-Being- Measures support and communication satisfaction. 3. Emotional Well-Being- Assesses sadness, anxiety, coping, and hope. 4. Functional Well-Being- Measures daily activities, contentment, and enjoyment. 5. Prostate Cancer Subsca
Conditions Studied
Interventions
- BEHAVIORAL Surveys for Quality of Life
- BEHAVIORAL Surveys and mHealth App access
Study Locations (3)
Florida
- Florida State University - Tallahassee
Georgia
- Georgia College & State University - Milledgeville
Oklahoma
- University of Oklahoma HSC - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2025-08-24 |
| Est. Completion | 2030-11 |
| Phase | NA |
What NCT06651359 shows while recruiting
NCT06651359 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Surveys for Quality of Life is the first listed.
NCT06651359 reports a single indexed study location in Florida, Georgia, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06651359 about?
NCT06651359 is a clinical study titled "Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors". The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their qua...
What is the current status of trial NCT06651359?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2025-08-24. Estimated completion is 2030-11.
What conditions does trial NCT06651359 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT06651359?
The interventions under investigation include: Surveys for Quality of Life (BEHAVIORAL), Surveys and mHealth App access (BEHAVIORAL).
Who is sponsoring clinical trial NCT06651359?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651359 being conducted?
This trial has 3 study locations across Florida, Georgia, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06651359's enrollment target sits among peer trials
248 187th of 735 higher than 549 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI